Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform

Journal of Cellular Biochemistry

Volumn 83, Issue 3, 2001, Pages 448-462

  Waters, Katrina M ^a   Rickard, David J ^a   Lawrence Riggs, B ^a   Khosla, Sundeep ^b   Katzenellenbogen, John A ^c   Katzenellenbogen, Benita S ^a   Moore, John ^d   Spelsberg, Thomas C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Bone cells; Cytokine synthesis; ER alpha and beta; Maturation; Mineralization; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; INTERLEUKIN 11; INTERLEUKIN 6; RECEPTOR SUBTYPE; TAMOXIFEN;

ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG POTENCY; ENZYME SYNTHESIS; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; EXTRACELLULAR MATRIX; GENES, REPORTER; HUMANS; LIGANDS; OSTEOBLASTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; TAMOXIFEN; TIME FACTORS;

EID: 0034764235     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.1242     Document Type: Article

References (50)

1. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
2. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SVHFO cells
3. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
4. Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression
5. Localization of estrogen receptor β protein expression in adult human bone
6. In vitro secretion of cytokines by human bone marrow: Effects of age and estrogen status
7. Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor
8. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines
9. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-Kilodalton glycoprotein in the rat decidua and a decidual cell line: Regulation by 17β-estradiol and prolactin
10. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-1, and parathyroid hormonestimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
11. Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element
12. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effects of estrogens
13. Interleukin-11: A new cytokine critical for osteoclast development
14. The estrogen receptor β isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
15. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
16. Estrogen response in hFOB1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene
17. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
18. Signal transduction from the extracellular matrix
19. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors
20. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
21. Involvement of different second messengers in parathyroid hormone- and interleukin-1-induced interleukin-6 and interleukin-11 production in human bone marrow stromal cells
22. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1- and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production
23. The effects of estrogen receptor gene disruption on bone
24. The novel estrogen receptor-β subtype: Potential role in the cell- and promoter-specific actions of estrogen and anti-estrogens
25. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
26. Localization of estrogen receptor-alpha in human and rabbit skeletal tissues
27. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts
28. Direct modulation of osteoblastic activity with estrogen
29. Bone marrow, cytokines, and bone remodeling
30. Nuclear receptor coregulators: Cellular and molecular biology
31. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels
32. Cloning and characterization of human estrogen receptor β isoforms
33. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
34. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures
35. Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α
36. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
37. 17β-estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner
38. Molecular and cellular mechanisms of estrogen action on the skeleton
39. Estrogen regulation of human osteoblastic cell proliferation and differentiation
40. Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1)promoter elements
41. Preparation of calcified tissues for light microscopy
42. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
43. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton
44. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1
45. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β
46. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: Association of receptor levels with alkaline phosphatase activity
47. Estrogen inhibition of periosteal bone formation in rat long bones: Down-regulation of gene expression for bone matrix proteins
48. Expression and localization of estrogen receptor-β in murine and human bone
49. Increased cortical bone mineral content but unchanged trabecular bone mineral density in adult female estrogen receptor-β-/- mice
50. Estrogen receptor activates the human retinoic acid receptor α-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen